<p><strong>公司在持续收入增长和企业采用后进入后急性护理的基础设施层</strong></p>
<p>底特律，2025 年 12 月 19 日（全球新闻通讯社）——Amesite Inc.（纳斯达克：AMST）今天宣布推出 NurseMagic™ EMR，标志着公司平台的重要扩展，此前经历了一年的强劲连续收入增长和企业吸引力。这款原生于人工智能的模块化 EMR 将 NurseMagic™从一个临床现场解决方案扩展到核心的后急性护理基础设施，支持与传统系统的共存和全面替代。Amesite 预计将在 2026 年 1 月开始为 EMR 客户提供服务。</p>
<p>Amesite 的收入增长与逐步推出更高价值产品层级的进展密切相关，从个人用户到团队、团队 + 和企业产品。自 2025 年 5 月推出团队 + 以来，公司报告季度收入增长了 2.4 倍。随着 2025 年 7 月推出的企业层级按患者人数定价，而非按个人用户定价，第四季度收入增长了 82%。企业能力的持续扩展和行业推广推动了 2026 财年第一季度收入环比增长了 69%。</p>
<p>麦肯锡估计，生成性人工智能每年可能创造 2.6 万亿到 4.4 万亿美元的经济价值，主要是在人工智能嵌入核心操作系统时，而不是作为独立工具使用。在自 2024 年 6 月公开发布以来的不到 18 个月内，NurseMagic™已从为个别临床医生提供的人工智能助手发展为具有基于患者人数定价的企业平台，现在又推出了原生于人工智能的 EMR。</p>
<p>美国的后急性护理市场是医疗保健中最大和增长最快的细分市场之一，2024 年估计价值超过 4700 亿美元，预计在未来几年将超过 8500 亿美元。增长的驱动因素包括老龄化人口、慢性疾病负担加重，以及支付者和政策向低成本、居家护理模式的持续转变。技术驱动的后急性护理已显示出显著的成本节约和临床结果。NurseMagic™目前为家庭健康、临终关怀、专业护理、老年生活和居家护理等后急性护理提供者服务。</p>
<p>“从销售的角度来看，这次发布特别强大的原因在于它为我们的客户提供了灵活性，并增强了我们在市场中的地位，” Amesite 的销售副总裁 Brandon Owens 表示。“我们可以与现有的 EMR 并行工作，提供即时的运营和财务影响而不造成干扰，或者我们可以完全替代它们，提供一个为后急性护理当前运作方式而构建的全 AI 原生 EMR。这种选择改变了每次对话的动态。买家不必在渐进式改进和全面变革之间做出选择。在竞争情况下，这是一个非常强大的销售立场，而传统系统根本无法匹配。”</p>
<p>“自 2025 年 1 月以来，网站访问量增加了近 1400%，反映出对可部署的人工智能解决方案在后急性护理中日益增长的认识，” Amesite 的企业运营总监 Madison Bush 表示。“随着我们扩展 NurseMagic™的能力和企业产品，这种兴趣转化为我们数字渠道的更高参与度，支持在 NurseMagic™ EMR 发布前的持续势头。”</p>
<p>“达到这个阶段反映了我们构建 NurseMagic™的严谨方式，” Amesite 的首席执行官兼创始人 Dr. Ann Marie Sastry 表示。“凭借一个原生于人工智能的 EMR、已证明的企业采用和与患者数量相一致的定价模型，我们正在将我们的平台扩展到后急性护理组织所依赖的核心系统。NurseMagic™ EMR 的推出标志着我们在提供以客户需求为基础的持久基础设施级解决方案战略中的重要一步。”</p>
<p><strong>关于 Amesite Inc.</strong></p>
<p>Amesite（纳斯达克：AMST）是一家以人工智能驱动的软件公司，专注于提供技术平台解决方案。其旗舰产品 NurseMagic™旨在简化临床文档、支持临床现场决策并提供可操作的运营洞察，已从个别临床医生的助手扩展为包括电子病历（EMR）产品的企业平台。NurseMagic™在所有 50 个州和 20 多个国家被超过 100 个职业使用。该平台基于专有的人工智能，旨在满足适用的监管和安全要求，服务于 B2B 和 B2C 用户，具备工作流程集成和多语言支持等功能。</p>
<p><strong>前瞻性声明</strong></p>
<p>本通讯包含前瞻性陈述（包括根据《1934 年证券交易法》第 21E 条及《1933 年证券法》第 27A 条的修订版的含义）有关公司、公司计划的在线机器学习平台、公司的商业计划、公司在线学习解决方案的未来商业化、潜在客户、商业目标及其他事项。前瞻性陈述通常包括预测性质的陈述，并依赖或提及未来事件或条件，包括诸如 “可能”、“将”、“应该”、“会”、“期望”、“计划”、“相信”、“打算”、“期待” 等类似表达。非历史事实的陈述即为前瞻性陈述。前瞻性陈述基于当前的信念和假设，这些信念和假设面临风险和不确定性，并不保证未来的表现。实际结果可能与任何前瞻性陈述中包含的内容有重大差异。公司及其计划平台面临的风险已在公司向 SEC 提交的文件中列出。除非法律要求，公司不承担修订或更新任何前瞻性陈述的义务，或因新信息、未来事件或其他原因作出任何其他前瞻性陈述。</p>
<p><strong>投资者关系</strong></p>
<p>ir@amesite.com</p>
<p><strong>来源</strong></p>
<ol>
<li>https://www.mckinsey.com/capabilities/tech-and-ai/our-insights/the-economic-potential-of-generative-ai-the-next-productivity-frontier</li>
<li>https://www.gminsights.com/industry-analysis/u-s-post-acute-care-market</li>
<li>https://www.ama-assn.org/public-health/population-health/hospital-home-saves-lives-and-money-cms-report</li>
</ol>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05EazRNaU0zTXpNd01UWTRJekl4T1RRME9EUT0?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05EazRNaU0zTXpNd01UWTRJekl4T1RRME9EUT0"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjAyMzg0YmQtYTQ3Zi00YzIzLThiZWMtNDMwYTlhYjM0MmVlLTEyMDYwMzctMjAyNS0xMi0xOS1lbg==/tiny/Amesite-Inc-.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjAyMzg0YmQtYTQ3Zi00YzIzLThiZWMtNDMwYTlhYjM0MmVlLTEyMDYwMzctMjAyNS0xMi0xOS1lbg==/tiny/Amesite-Inc-.png"/></p>

AMST

<p>Amesite Inc. 推出了 AI 原生的 NurseMagic™ 电子病历系统（EMR），将其平台扩展到急性后护理基础设施。这是在显著的收入增长和企业采用之后进行的。该电子病历系统支持传统系统的共存和全面替代，客户入驻将于 2026 年 1 月开始。美国的急性后护理市场正在快速增长，受到人口和政策变化的推动。Amesite 灵活的电子病历解决方案增强了其市场地位，提供了运营和财务上的好处而不造成干扰。此次发布标志着在提供基础设施级解决方案方面的战略性一步</p>

<p><strong>Company enters the infrastructure layer of post-acute care following sustained revenue expansion and enterprise adoption</strong></p>
<div class="lb-trans"><p><strong>公司在持续收入增长和企业采用后进入后急性护理的基础设施层</strong></p>
</div><p>DETROIT, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST) today announced the launch of the NurseMagic™ EMR, marking a significant expansion of the Company’s platform following a year of strong sequential revenue growth and enterprise traction. The AI-native, modular EMR extends NurseMagic™ from a point-of-care solution into core post-acute care infrastructure, supporting both coexistence with legacy systems and full system replacement. Amesite expects to begin onboarding EMR customers in January 2026.</p>
<div class="lb-trans"><p>底特律，2025 年 12 月 19 日（全球新闻通讯社）——Amesite Inc.（纳斯达克：AMST）今天宣布推出 NurseMagic™ EMR，标志着公司平台的重要扩展，此前经历了一年的强劲连续收入增长和企业吸引力。这款原生于人工智能的模块化 EMR 将 NurseMagic™从一个临床现场解决方案扩展到核心的后急性护理基础设施，支持与传统系统的共存和全面替代。Amesite 预计将在 2026 年 1 月开始为 EMR 客户提供服务。</p>
</div><p>Amesite’s revenue growth has occurred in clear step changes aligned with the rollout of progressively higher-value product tiers, progressing from Individual to Teams, Teams+, and Enterprise offerings. Following the May 2025 launch of Teams+, the Company reported a 2.4x increase in quarterly revenue. With the July 2025 introduction of its Enterprise tier, priced on patient census rather than individual users, revenues increased 82% in the fourth quarter. Continued expansion of Enterprise capabilities and industry outreach drove an additional 69% quarter-over-quarter revenue increase in the first quarter of fiscal 2026.</p>
<div class="lb-trans"><p>Amesite 的收入增长与逐步推出更高价值产品层级的进展密切相关，从个人用户到团队、团队 + 和企业产品。自 2025 年 5 月推出团队 + 以来，公司报告季度收入增长了 2.4 倍。随着 2025 年 7 月推出的企业层级按患者人数定价，而非按个人用户定价，第四季度收入增长了 82%。企业能力的持续扩展和行业推广推动了 2026 财年第一季度收入环比增长了 69%。</p>
</div><p>McKinsey estimates that generative AI could create $2.6 trillion to $4.4 trillion in annual economic value, primarily when AI is embedded into core operating systems rather than used as standalone tools.1 In under 18 months since its June 2024 public launch, NurseMagic™ has progressed from an AI assistant for individual clinicians to an enterprise platform with census-based pricing and now an AI-native EMR.</p>
<div class="lb-trans"><p>麦肯锡估计，生成性人工智能每年可能创造 2.6 万亿到 4.4 万亿美元的经济价值，主要是在人工智能嵌入核心操作系统时，而不是作为独立工具使用。在自 2024 年 6 月公开发布以来的不到 18 个月内，NurseMagic™已从为个别临床医生提供的人工智能助手发展为具有基于患者人数定价的企业平台，现在又推出了原生于人工智能的 EMR。</p>
</div><p>The U.S. post-acute care market is one of healthcare’s largest and fastest-growing segments, valued at more than $470 billion in 2024 and projected to exceed $850 billion in the coming years. Growth is driven by an aging population, rising chronic disease burden, and sustained payer and policy shifts toward lower-cost, home-based care models.2 Technology-enabled post-acute care has demonstrated meaningful cost savings and clinical outcomes.3 NurseMagic™ currently serves post-acute providers across home health, hospice, skilled nursing, senior living, and home care.</p>
<div class="lb-trans"><p>美国的后急性护理市场是医疗保健中最大和增长最快的细分市场之一，2024 年估计价值超过 4700 亿美元，预计在未来几年将超过 8500 亿美元。增长的驱动因素包括老龄化人口、慢性疾病负担加重，以及支付者和政策向低成本、居家护理模式的持续转变。技术驱动的后急性护理已显示出显著的成本节约和临床结果。NurseMagic™目前为家庭健康、临终关怀、专业护理、老年生活和居家护理等后急性护理提供者服务。</p>
</div><p>“What makes this launch particularly powerful from a sales perspective is the flexibility it gives our customers, and how it strengthens our position in the market,” said Brandon Owens, VP of Sales at Amesite. “We can work alongside existing EMRs, delivering immediate operational and financial impact without disruption, or we can replace them entirely with a full AI‑native EMR built for how post‑acute care operates today. That optionality changes the dynamic in every conversation. Buyers don’t have to choose between incremental improvement and wholesale change. In competitive situations, that’s a very strong position to sell from, and one that legacy systems simply can’t match.”</p>
<div class="lb-trans"><p>“从销售的角度来看，这次发布特别强大的原因在于它为我们的客户提供了灵活性，并增强了我们在市场中的地位，” Amesite 的销售副总裁 Brandon Owens 表示。“我们可以与现有的 EMR 并行工作，提供即时的运营和财务影响而不造成干扰，或者我们可以完全替代它们，提供一个为后急性护理当前运作方式而构建的全 AI 原生 EMR。这种选择改变了每次对话的动态。买家不必在渐进式改进和全面变革之间做出选择。在竞争情况下，这是一个非常强大的销售立场，而传统系统根本无法匹配。”</p>
</div><p>“Since January 2025, website visits have increased by nearly 1,400%, reflecting growing awareness of deployable AI solutions in post-acute care,” said Madison Bush, Director of Corporate Operations at Amesite. “As we expanded NurseMagic™’s capabilities and enterprise offerings, that interest translated into higher engagement across our digital channels, supporting continued momentum leading into the launch of the NurseMagic™ EMR.”</p>
<div class="lb-trans"><p>“自 2025 年 1 月以来，网站访问量增加了近 1400%，反映出对可部署的人工智能解决方案在后急性护理中日益增长的认识，” Amesite 的企业运营总监 Madison Bush 表示。“随着我们扩展 NurseMagic™的能力和企业产品，这种兴趣转化为我们数字渠道的更高参与度，支持在 NurseMagic™ EMR 发布前的持续势头。”</p>
</div><p>“Reaching this stage reflects the disciplined way we have built NurseMagic™,” said Dr. Ann Marie Sastry, CEO and Founder of Amesite. “With an AI-native EMR, demonstrated enterprise adoption, and a pricing model aligned with patient volumes, we are extending our platform into the core systems that post-acute care organizations depend on. The launch of the NurseMagic™ EMR marks an important step in our strategy to deliver durable, infrastructure-level solutions anchored in customer requirements.”</p>
<div class="lb-trans"><p>“达到这个阶段反映了我们构建 NurseMagic™的严谨方式，” Amesite 的首席执行官兼创始人 Dr. Ann Marie Sastry 表示。“凭借一个原生于人工智能的 EMR、已证明的企业采用和与患者数量相一致的定价模型，我们正在将我们的平台扩展到后急性护理组织所依赖的核心系统。NurseMagic™ EMR 的推出标志着我们在提供以客户需求为基础的持久基础设施级解决方案战略中的重要一步。”</p>
</div><p><strong>About Amesite Inc.</strong></p>
<div class="lb-trans"><p><strong>关于 Amesite Inc.</strong></p>
</div><p>Amesite (NASDAQ: AMST) is an AI-driven software company focused on delivering technology platform solutions. Its flagship product, NurseMagic™, is designed to streamline clinical documentation, support point-of-care decision-making, and deliver actionable operational insight, and has expanded from an assistant for individual clinicians into an enterprise platform that includes an electronic medical record (EMR) offering. NurseMagic™ is used by used by over 100 professions across all 50 states and over 20 countries. Built on proprietary AI and designed to meet applicable regulatory and security requirements, the platform serves B2B and B2C users with capabilities that include workflow integration and multilingual support.</p>
<div class="lb-trans"><p>Amesite（纳斯达克：AMST）是一家以人工智能驱动的软件公司，专注于提供技术平台解决方案。其旗舰产品 NurseMagic™旨在简化临床文档、支持临床现场决策并提供可操作的运营洞察，已从个别临床医生的助手扩展为包括电子病历（EMR）产品的企业平台。NurseMagic™在所有 50 个州和 20 多个国家被超过 100 个职业使用。该平台基于专有的人工智能，旨在满足适用的监管和安全要求，服务于 B2B 和 B2C 用户，具备工作流程集成和多语言支持等功能。</p>
</div><p><strong>Forward-Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as &#34;may,&#34; &#34;will,&#34; &#34;should,&#34; &#34;would,&#34; &#34;expect,&#34; &#34;plan,&#34; &#34;believe,&#34; &#34;intend,&#34; &#34;look forward,&#34; and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.</p>
<div class="lb-trans"><p>本通讯包含前瞻性陈述（包括根据《1934 年证券交易法》第 21E 条及《1933 年证券法》第 27A 条的修订版的含义）有关公司、公司计划的在线机器学习平台、公司的商业计划、公司在线学习解决方案的未来商业化、潜在客户、商业目标及其他事项。前瞻性陈述通常包括预测性质的陈述，并依赖或提及未来事件或条件，包括诸如 “可能”、“将”、“应该”、“会”、“期望”、“计划”、“相信”、“打算”、“期待” 等类似表达。非历史事实的陈述即为前瞻性陈述。前瞻性陈述基于当前的信念和假设，这些信念和假设面临风险和不确定性，并不保证未来的表现。实际结果可能与任何前瞻性陈述中包含的内容有重大差异。公司及其计划平台面临的风险已在公司向 SEC 提交的文件中列出。除非法律要求，公司不承担修订或更新任何前瞻性陈述的义务，或因新信息、未来事件或其他原因作出任何其他前瞻性陈述。</p>
</div><p><strong>Investor Relations</strong></p>
<div class="lb-trans"><p><strong>投资者关系</strong></p>
</div><p>ir@amesite.com</p>
<div class="lb-trans"><p>ir@amesite.com</p>
</div><p><strong>Sources</strong></p>
<div class="lb-trans"><p><strong>来源</strong></p>
</div><ol>
<li>https://www.mckinsey.com/capabilities/tech-and-ai/our-insights/the-economic-potential-of-generative-ai-the-next-productivity-frontier</li>
<li>https://www.gminsights.com/industry-analysis/u-s-post-acute-care-market</li>
<li>https://www.ama-assn.org/public-health/population-health/hospital-home-saves-lives-and-money-cms-report</li>
</ol>
<div class="lb-trans"><ol>
<li>https://www.mckinsey.com/capabilities/tech-and-ai/our-insights/the-economic-potential-of-generative-ai-the-next-productivity-frontier</li>
<li>https://www.gminsights.com/industry-analysis/u-s-post-acute-care-market</li>
<li>https://www.ama-assn.org/public-health/population-health/hospital-home-saves-lives-and-money-cms-report</li>
</ol>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZd05EazRNaU0zTXpNd01UWTRJekl4T1RRME9EUT0" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYwNDk4MiM3MzMwMTY4IzIxOTQ0ODQ="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/NjAyMzg0YmQtYTQ3Zi00YzIzLThiZWMtNDMwYTlhYjM0MmVlLTEyMDYwMzctMjAyNS0xMi0xOS1lbg==/tiny/Amesite-Inc-.png" alt="" original-src="https://ml.globenewswire.com/media/NjAyMzg0YmQtYTQ3Zi00YzIzLThiZWMtNDMwYTlhYjM0MmVlLTEyMDYwMzctMjAyNS0xMi0xOS1lbg==/tiny/Amesite-Inc-.png"/></p>

Amesite 通过推出 AI 原生的 NurseMagic™电子病历系统加速发展 | AMST 股票新闻